Pharvaris Netherlands B.v.
Clinical trials sponsored by Pharvaris Netherlands B.v., explained in plain language.
-
New pill shows promise for rapid relief from rare, painful swelling attacks
Symptom relief CompletedThis completed Phase 3 trial tested whether an oral capsule called deucrictibant could safely and quickly relieve sudden swelling attacks in people with hereditary angioedema (HAE). The study involved 134 participants aged 12 to 75 who took either the study drug or a placebo pill…
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
New pill tested to stop painful swelling attacks
Symptom relief CompletedThis study tested an oral medication called deucrictibant for quickly relieving painful swelling attacks in people with hereditary angioedema (HAE). Seventy-four participants with HAE took either the study drug or a placebo pill at home when an attack started. Researchers measure…
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC